Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Evogene Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 3 filings
- 2 insiders, $692.8K in total
- Open-market sells
- 0 filings
- Insiders trading
- 2
- Net value
- +$692.8K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Evogene Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tarcic Gabi | Chief Development Officer | 1,129 | Aug 26, 2026 | 1 |
| Recanati Leon | Director | 1,343,886 | Aug 13, 2026 | 2 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 (view filing)4:00 PM ET | Jun 4 | 83 daysLate | Tarcic GabiChief Development Officer | PPurchase | +1.13K | $0.60 | +$677.4 | New position1.13K after | |
| Aug 13, 2026 (view filing)7:00 AM ET | Aug 11 | 2 days | Recanati LeonDirector | PPurchase | +460.0K | $0.635 | +$292.1K | +52.0%1.34M after | |
| Aug 5, 2026 (view filing)4:07 PM ET | Aug 4 | 1 day | Recanati LeonDirector | PPurchase | +800.0K | $0.50 | +$400.0K | +953.7%883.9K after |